Research Analysts Issue Forecasts for GlaxoSmithKline plc's Q1 2018 Earnings


Equities researchers at Leerink Swann issued their Q1 2018 earnings estimates for shares of GlaxoSmithKline in a research note issued to investors on Thursday. Leerink Swann analyst S. Fernandez anticipates that the pharmaceutical company will post earnings per share of $0.69 for the quarter.



from Biotech News